First outbreak of Oropouche in Cuba: epidemiological characterization, 2024

For decades, the tropical Americas have been a battleground for a specific kind of invisible enemy: viruses carried by insects. These arthropod-borne viruses, often called arboviruses, are responsible for a significant portion of the infectious diseases that threaten human health in warm climates. While diseases like dengue and Zika have dominated headlines in recent years, another virus has been quietly circulating in the dense rainforests of the Amazon basin for nearly a century. This is the Oropouche virus, a pathogen that causes a sudden, intense fever and has historically remained confined to remote jungle regions. However, the landscape of infectious disease is rarely static. In late 2023, a new genetic version of this virus emerged, breaking its historical boundaries and spreading rapidly across Latin America. This shift transformed a localized jungle concern into a regional public health emergency, forcing scientists to ask how quickly a virus can adapt to new environments and how severe its impact might be on populations that have never encountered it before.

In 2024, this expanding threat reached the island nation of Cuba, marking the first time the virus was detected there. A team of researchers from the Cuban Ministry of Health and the Institute "Pedro Kourí" set out to map the outbreak as it unfolded. They conducted a detailed review of every case reported from May through December of that year, analyzing data from hospitals, clinics, and local health centers across all fifteen provinces of the country. Their goal was not just to count the sick, but to understand who was getting infected, how the illness presented itself, and whether the virus was causing unexpected complications in a population with no prior immunity.

The results revealed a rapid and widespread invasion. From the moment the first cases were identified in late May until the end of the year, health officials recorded nearly twenty-four thousand suspected cases of Oropouche fever. Of these, more than six hundred were confirmed through laboratory testing, a number that represented a significant outbreak for a virus previously unknown to the island. The spread was remarkably fast; within weeks of the initial detection, the virus had reached every single province and the vast majority of the country's municipalities. The outbreak did not stay contained in one area; it swept through the entire nation, with the highest number of cases appearing in the capital, Havana, followed by Santiago de Cuba.

The people falling ill were not a random cross-section of the population. The data showed a distinct pattern: the virus struck hardest at young adults, particularly those between the ages of twenty and thirty-nine, who made up a quarter of all confirmed cases. Women were slightly more likely to be reported as sick than men. While the virus affected people of all ages, from infants to the elderly, the very young and the very old were less frequently represented in the confirmed numbers. This distribution suggests that the virus found its most fertile ground in the socially active, working-age population, likely due to their daily movements and exposure to the insects that carry the virus.

The illness itself followed a familiar but intense script for most patients. The majority of those infected experienced a sudden onset of high fever, severe headaches, and pain in the muscles and joints, symptoms that typically last for about a week. For more than half of the confirmed patients, the sickness was manageable enough that they could recover at home under the care of their local family doctors. This reliance on primary care was a crucial part of the response, allowing the hospital system to focus on the most severe cases. However, the outbreak was not without its dangers. While most cases were self-limiting, the virus proved capable of causing serious harm in a significant number of patients.

Nearly one in five confirmed cases developed neurological complications, a finding that stood out as a major concern. The virus did not just cause fever; in some instances, it attacked the nervous system. The most common severe complication was a condition known as Guillain-Barré Syndrome, a disorder where the body's immune system attacks the nerves, leading to weakness and paralysis. This was followed by cases of inflammation of the brain and the membranes surrounding it. These severe outcomes were not limited to a single region; they appeared in provinces across the island, indicating that the risk of neurological damage was a consistent feature of this outbreak. The presence of these complications in a population that had never seen the virus before highlights the unpredictable nature of emerging diseases.

The speed at which the virus moved through Cuba, combined with the severity of the neurological complications, underscores a changing reality for infectious disease surveillance. The outbreak in 2024 was not a slow, creeping spread but a rapid, nationwide event that tested the limits of the country's health monitoring systems. The researchers concluded that while the virus mostly caused mild illness, its ability to trigger severe neurological issues and its rapid geographic expansion require a heightened state of alert. The findings serve as a stark reminder that viruses can evolve and move quickly, turning a historical jungle pathogen into a modern urban threat, and that the only way to stay ahead is through constant, rigorous observation of the disease as it moves through the population.